1. Home
  2. JVA vs PBMWW Comparison

JVA vs PBMWW Comparison

Compare JVA & PBMWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JVA
  • PBMWW
  • Stock Information
  • Founded
  • JVA 1971
  • PBMWW N/A
  • Country
  • JVA United States
  • PBMWW Canada
  • Employees
  • JVA N/A
  • PBMWW 10
  • Industry
  • JVA Packaged Foods
  • PBMWW
  • Sector
  • JVA Consumer Staples
  • PBMWW
  • Exchange
  • JVA Nasdaq
  • PBMWW Nasdaq
  • Market Cap
  • JVA N/A
  • PBMWW N/A
  • IPO Year
  • JVA 2005
  • PBMWW N/A
  • Fundamental
  • Price
  • JVA $4.06
  • PBMWW $0.01
  • Analyst Decision
  • JVA
  • PBMWW
  • Analyst Count
  • JVA 0
  • PBMWW 0
  • Target Price
  • JVA N/A
  • PBMWW N/A
  • AVG Volume (30 Days)
  • JVA 119.7K
  • PBMWW N/A
  • Earning Date
  • JVA 02-07-2025
  • PBMWW N/A
  • Dividend Yield
  • JVA N/A
  • PBMWW N/A
  • EPS Growth
  • JVA N/A
  • PBMWW N/A
  • EPS
  • JVA 0.20
  • PBMWW N/A
  • Revenue
  • JVA $76,111,698.00
  • PBMWW N/A
  • Revenue This Year
  • JVA N/A
  • PBMWW N/A
  • Revenue Next Year
  • JVA N/A
  • PBMWW N/A
  • P/E Ratio
  • JVA $20.62
  • PBMWW N/A
  • Revenue Growth
  • JVA 17.27
  • PBMWW N/A
  • 52 Week Low
  • JVA $0.95
  • PBMWW N/A
  • 52 Week High
  • JVA $4.66
  • PBMWW N/A
  • Technical
  • Relative Strength Index (RSI)
  • JVA 56.72
  • PBMWW N/A
  • Support Level
  • JVA $3.32
  • PBMWW N/A
  • Resistance Level
  • JVA $4.01
  • PBMWW N/A
  • Average True Range (ATR)
  • JVA 0.33
  • PBMWW 0.00
  • MACD
  • JVA -0.04
  • PBMWW 0.00
  • Stochastic Oscillator
  • JVA 55.22
  • PBMWW 0.00

About PBMWW Psyence Biomedical Ltd. Warrant

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: